UNLABELLED: BACKGROUND AND PURPOSE; Chronic joint inflammation and pain are the hallmarks of disease in patients with inflammatory arthritis, notably rheumatoid arthritis. The aim of the present study was to investigate the relative contribution of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and neutrophil influx for joint inflammation and nociception in a novel murine model of antigen-induced arthritis (AIA). EXPERIMENTAL APPROACH: AIA was induced by administration of antigen into knee joint of previously immunized mice. Neutrophil accumulation was determined by counting neutrophils in the joints and assessing myeloperoxidase activity in tissues surrounding the joints. TNF-α, IL-1β and CXCL-1 were measured by elisa. Mechanical hypernociception was assessed in parallel, using an electronic pressure meter. KEY RESULTS: Hypernociception was dependent on antigen dose and the time after its administration; it was prevented by treatment with morphine and associated with neutrophil infiltration and local production of TNF-α, IL-1β and CXCL-1. Administration of a chimeric monoclonal antibody to TNF-α (infliximab) or IL-1receptor antagonist prevented neutrophil influx and hypernociception, and this was comparable to the effects of dexamethasone. Treatment with fucoidin (a leucocyte adhesion inhibitor) greatly suppressed neutrophil influx and local production of TNF-α and IL-1β, and hypernociception. CONCLUSIONS AND IMPLICATIONS: In conclusion, the present study describes a new model that allows for the concomitant evaluation of articular hypernociception and inflammation. Using this system, we demonstrated that a positive feedback loop involving neutrophil influx and the pro-inflammatory cytokines TNF-α and IL-1β is necessary for articular hypernociception after antigen challenge of immunized mice.
UNLABELLED: BACKGROUND AND PURPOSE; Chronic joint inflammation and pain are the hallmarks of disease in patients with inflammatory arthritis, notably rheumatoid arthritis. The aim of the present study was to investigate the relative contribution of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and neutrophil influx for joint inflammation and nociception in a novel murine model of antigen-induced arthritis (AIA). EXPERIMENTAL APPROACH: AIA was induced by administration of antigen into knee joint of previously immunized mice. Neutrophil accumulation was determined by counting neutrophils in the joints and assessing myeloperoxidase activity in tissues surrounding the joints. TNF-α, IL-1β and CXCL-1 were measured by elisa. Mechanical hypernociception was assessed in parallel, using an electronic pressure meter. KEY RESULTS: Hypernociception was dependent on antigen dose and the time after its administration; it was prevented by treatment with morphine and associated with neutrophil infiltration and local production of TNF-α, IL-1β and CXCL-1. Administration of a chimeric monoclonal antibody to TNF-α (infliximab) or IL-1receptor antagonist prevented neutrophil influx and hypernociception, and this was comparable to the effects of dexamethasone. Treatment with fucoidin (a leucocyte adhesion inhibitor) greatly suppressed neutrophil influx and local production of TNF-α and IL-1β, and hypernociception. CONCLUSIONS AND IMPLICATIONS: In conclusion, the present study describes a new model that allows for the concomitant evaluation of articular hypernociception and inflammation. Using this system, we demonstrated that a positive feedback loop involving neutrophil influx and the pro-inflammatory cytokines TNF-α and IL-1β is necessary for articular hypernociception after antigen challenge of immunized mice.
Authors: Danielle G Souza; Adriana C Soares; Vanessa Pinho; Humberto Torloni; Luiz F L Reis; Mauro M Teixeira; Adriana A M Dias; Mauro T Martins Journal: Am J Pathol Date: 2002-05 Impact factor: 4.307
Authors: D G Souza; D C Cara; G D Cassali; S F Coutinho; M R Silveira; S P Andrade; S P Poole; M M Teixeira Journal: Br J Pharmacol Date: 2000-12 Impact factor: 8.739
Authors: Danielle G Souza; Vanessa Pinho; Giovanni D Cassali; Stephen Poole; Mauro M Teixeira Journal: Eur J Pharmacol Date: 2002-04-05 Impact factor: 4.432
Authors: Carlos Amilcar Parada; Gustavo Gameiro Vivancos; Claudia Herrera Tambeli; Fernando de Queiróz Cunha; Sérgio Henrique Ferreira Journal: Proc Natl Acad Sci U S A Date: 2003-02-14 Impact factor: 11.205
Authors: Waldiceu A Verri; Ieda R S Schivo; Thiago M Cunha; Foo Y Liew; Sergio H Ferreira; Fernando Q Cunha Journal: J Pharmacol Exp Ther Date: 2004-03-29 Impact factor: 4.030
Authors: Vivian V Costa; Caio T Fagundes; Deborah F Valadão; Daniel Cisalpino; Ana Carolina F Dias; Kátia D Silveira; Lucas M Kangussu; Thiago V Ávila; Maria Rosa Q Bonfim; Daniela Bonaventura; Tarcília A Silva; Lirlândia P Sousa; Milene A Rachid; Leda Q Vieira; Gustavo B Menezes; Ana Maria de Paula; Alena Atrasheuskaya; George Ignatyev; Mauro M Teixeira; Danielle G Souza Journal: PLoS Negl Trop Dis Date: 2012-05-29
Authors: Vivian V Costa; Flavio A Amaral; Fernanda M Coelho; Celso M Queiroz-Junior; Bruna G Malagoli; Jose Hugo S Gomes; Fernando Lopes; Kátia D Silveira; Daniela Sachs; Caio T Fagundes; Lívia D Tavares; Vanessa Pinho; Tarcilia A Silva; Mauro M Teixeira; Fernão C Braga; Danielle G Souza Journal: PLoS One Date: 2015-03-20 Impact factor: 3.240
Authors: Andrew D Cook; Cynthia Louis; Matthew J Robinson; Reem Saleh; Matthew A Sleeman; John A Hamilton Journal: Arthritis Res Ther Date: 2016-12-01 Impact factor: 5.156
Authors: Pablo V M Reis; Daiane Boff; Rodrigo M Verly; Marcella N Melo-Braga; María E Cortés; Daniel M Santos; Adriano M de C Pimenta; Flávio A Amaral; Jarbas M Resende; Maria E de Lima Journal: Front Microbiol Date: 2018-04-06 Impact factor: 5.640
Authors: Anthony G Doufas; Lu Tian; Kevin A Padrez; Puntarica Suwanprathes; James A Cardell; Holden T Maecker; Periklis Panousis Journal: PLoS One Date: 2013-01-29 Impact factor: 3.240
Authors: India C Severin; Adriano Soares; Jennifer Hantson; Mauro Teixeira; Daniela Sachs; Delphine Valognes; Alexander Scheer; Matthias K Schwarz; Timothy N C Wells; Amanda E I Proudfoot; Jeffrey Shaw Journal: Front Immunol Date: 2012-10-16 Impact factor: 7.561
Authors: Marina C Oliveira; Luciana P Tavares; Juliana P Vago; Nathália V Batista; Celso M Queiroz-Junior; Angelica T Vieira; Gustavo B Menezes; Lirlândia P Sousa; Fons A J van de Loo; Mauro M Teixeira; Flávio A Amaral; Adaliene V M Ferreira Journal: PLoS One Date: 2016-01-07 Impact factor: 3.240